Atractylenolide III is an organic product of the herb plant Atractylodes ovata that is used as an anti-inflammatory. This compound has very limited solubility in water, but we succeeded in transforming it using a Chlamydomonas cell disruptant containing 9.1% dimethyl sulfoxide. Two types of metabolites were confirmed after 3 h of incubation by gas chromatography, besides the non-modified substrate. Nuclear magnetic resonance and gas chromatography-mass spectrometry analyses indicated that one of the metabolites had two hydroxyl groups whereas atractylenolide III had one hydroxyl group, but no metabolite was obtained when atractylenolide III was added directly to the Chlamydomonas culture medium for 10 d.
Plants produce a wide variety of secondary metabolites, [1] [2] [3] including hydrocarbons, alkaloids, and steroids. Many of these metabolites participate in the survival of the plant. 4) Bioconversion of organic compounds is a very promising field, 5, 6) since it makes possible environmentally friendly production of valuable metabolites more inexpensively than traditional synthetic methods, which often use heavy metal catalysts. Recently, Furusawa et al. 7) reported the conversion of sesquiterpene obtained from the Valencia orange into an expensive aromatic, nootkatone, by the addition of orange oil to the culturing medium of Chlorella for 20 d. Besides that study, many investigations have reported the successful biotransformation of chemical compounds using various bacteria (e.g., Enterobacter sp.) or fungi (e.g., Aspergillus niger, Fusarium culmorum, Botryosphaeria dothidea). 7) However, as far as we know, little attention has been paid to heterogeneous biotransformation systems using cell disruptants for materials that are poorly transportable in the cell matrix. In this experiment, we found the cell disruptant of the unicellular green alga Chlamydomonas reinhardtii to be very promising for this purpose.
Cell culture and preparation of the cell disruptant were carried out as follows: A wild-type strain of C. reinhardtii, obtained from the Chlamydomonas Genetics Center (Duke University, Durham, NC), was cultured under moderate, constant white fluorescent light (20 mmol m À2 s À1 ) at 25 C with vigorous shaking in TAP (Tris-Acetate-Phosphate) medium without acetic acid (pH 7.0), that is under autotrophic conditions. 8) When the cells reached mid-log phase (about 2 Â 10 6 cells/ml), they were collected from 20-ml samples of the culture by centrifugation, and the pellet was resuspended in the 5 ml TAP medium. The cell suspension was then introduced into a gas pressure device, Mini-Bom Cell (Kontes, Vineland, NJ), and disrupted once at 10.5 Pa under nitrogen.
9)
We compared four different conditions under which to transform atractylenolide III, 1) a natural organic product of the herb plant Atractylodes ovata. First, atractylenolide III 1) (20 mg) was added directly to 20 ml of Chlamydomonas reinhardtii culture when the cell density was about 1 Â 10 3 /ml and kept in the culture medium under white fluorescent light with vigorous shaking for 10 d. Second, the same amount of atractylenolide III 1) was added directly to the cell disruptant and this was shaken gently at 25 C for 3 h. Third, the same amount of the compound dissolved in 0.5 ml of dimethyl sulfoxide (DMSO) was added to the disruptant and this was mixed gently for 3 h, as described above (the final concentration of DMSO in the cell disruptant was 9.1% v/v). Fourth, the same amount was added to disruptant containing 9.0% v/v ethanol. After treatments for biotransformation, atractylenolide III 1) and its metabolites were extracted with ether. The ether extract was concentrated to give a residue, which was redissolved with ether and analyzed by gas chromatography. The ether extract was also subjected to ODS high performance liquid chromatography (HPLC) using H 2 O-MeOH (20:80, v/v). The HPLC-separated metabolites in each peak were then analyzed by 1D and 2D nuclear magnetic resonance (NMR) and gas chromatography-mass spectrometry (GC/MS).
No metabolites were detected by gas chromatography analysis when atractylenolide III 1) was added directly to the C. reinhardtii culturing medium or when the compound was incubated in the cell disruptant without DMSO or containing 9.0% ethanol. On the other hand, at least two metabolites were confirmed in addition to the non-transformed atractylenolide III 1) by the gas chromatography ( Fig. 1) and HPLC (data not shown) analyses, when the substrate dissolved in 0.5 ml DMSO was added to 5 ml cell disruptant and incubated for 3 h.
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10,11) The structure of peak 3 substrate was not determined due to limited amount of the sample. The ratio of gas chromatography of peaks 1:2:3 was 45:43:9.
The solubility of atractylenolide III in water was very limited, while it was completely dissolved in the C. reinhardtii cell disruptant containing 9.0% ethanol or 9.1% DMSO. On the other hand, metabolites were obtained only when atractylenolide III was incubated in DMSO containing the cell disruptant. This suggests that C. reinhardtii bears no authentic enzymes that can modify atractylenolide III 1) which is left unsolved in water or completely solved in ethanol, but in the disruptant containing 9.1% DMSO, the three-dimensional structure of some enzymes might have been distorted and might have misrecognized atractylenolide III 1) as their substrate. One such candidate is cytochrome P450 monooxygenease (CYP), because a wide variety of terpenoids are good substrates for plant CYPs and many CYP genes have been detected in the Chlamydomonas genome. 12) We carried out similar experiments using a cell disruptant of Euglena gracilis (NIES-48) obtained from the National Institute for Environmental Studies (Tsukuba, Japan), which was cultured in Cramer-Myers medium, 13) but no metabolites of atractylenolide III were detected using the cell disruptant with or without 9.1% DMSO (data not shown). This implies that E. gracilis has no appropriate enzymes to transform atractylenolide III.
At present, our knowledge of secondary metabolite pathways in algae is very limited, and thus it is very difficult to predict how organic compounds will be modified in a cell disruptant. Further experiments are needed to accumulate further biotransformation data such as those reported here. 
